OpenAI scales Cerebras allocation — Colossus footprint now serves ChatGPT inference at production scale

OpenAI's $20B multi-year Cerebras commitment is now operational at ChatGPT-inference scale. The deployment converts what was an experimental procurement-diversification move in January into production substrate for the consumer product. The Cerebras IPO last week priced in this scenario; the volume ramp validates it.

The strategic point is that OpenAI now has redundant inference substrates at hyperscale — NVIDIA HGX, Cerebras WSE, and (per public statements) an in-development custom chip with Broadcom. Single-vendor concentration risk drops materially, and the procurement-leverage position improves on every renegotiation cycle.

For Cerebras, the story is harder. The IPO priced the company as a category-defining second source. The Q3 question is whether other Tier-1 labs sign nine-figure multi-year deals — Anthropic and xAI being the obvious candidates — or whether OpenAI remains an idiosyncratic procurement decision.

Network World — OpenAI-Cerebras mega deal → · nat.io — non-NVIDIA compute shift →